Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021
HomeRa Medical SystemsPharos, Optimized Dermatology Excimer Laser Launched

Pharos, Optimized Dermatology Excimer Laser Launched

Today Ra Medical Systems, Inc.announced the launch of Pharos, Optimized, the next generation of Pharos excimer lasers, designed to enhance physician and patient experience with faster treatments for psoriasis, vitiligo, and atopic dermatitis; extended peak performance; and a new ergonomic handpiece for operator comfort and greater treatment site visibility.

“Pharos has added significant value to my dermatology practice by quickly and painlessly treating stubborn conditions: psoriasis, vitiligo, and atopic dermatitis,” said David J. Goldberg, MD. “Faster treatments from the optimized Pharos laser will increase patient satisfaction and motivate patients to complete the full treatment regimen to achieve the best possible outcomes.” Dr. Goldberg is a widely-published, world-renowned dermatologic laser expert and is the director of Skin Laser & Surgery Specialists of New York and New Jersey.

Psoriasis1, vitiligo2, and atopic dermatitis3 collectively affect more than 25 million people in the United States. Pharos, Optimized brings together 15 years of proven clinical success treating these conditions with a user-centered design that reflects customer experience with millions of procedures in the U.S. and 14 countries worldwide.

“The Pharos excimer laser is a workhorse in my practice, treating chronic skin conditions that affect large patient populations. With Pharos, I achieve clinical success clearing plaques and re-pigmenting lesions that have not responded to other treatments,” said Tien Q. Nguyen, MD. “Ra Medical Systems provides excellent clinical and post-sales support with no recurring per treatment expense to my practice.” Dr. Nguyen is the director of First OC Dermatology in Irvine and Fountain Valley, CA.

Pharos is the only excimer laser to feature integrated adjustable aiming and laser beams to deliver precisely targeted treatments that spare healthy tissue. The laser’s small footprint enables it to fit into any treatment room, saving valuable floor space.

“The optimized Pharos is a next generation laser that delivers what dermatologists have been asking for: faster treatments for psoriasis, vitiligo, and atopic dermatitis and an upgraded user and patient experience,” said Dean Irwin, CEO, Ra Medical Systems, Inc.

Pharos, Optimized will make its debut at the 2019 American Academy of Dermatology Summer Meeting, which takes place from July 25-28, 2019 at the Hilton Midtown in New York, NY. Visit Ra Medical’s Booth No. 830 at the AAD or click to watch the video to learn more.


References

1 https://www.psoriasis.org/content/statistics
2 https://www.aad.org/File%20Library/Top%20navigation/About/Burden%20of%20Skin%20Disease/Vitiligo.pdf
3 https://nationaleczema.org/research/eczema-facts/

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy